These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15972344)

  • 1. Scleroderma and failed response to alefacept.
    Chi GC; Hsu FS; Yang CC; Wei JC
    Rheumatology (Oxford); 2005 Oct; 44(10):1328-30. PubMed ID: 15972344
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment with leflunomide of arthritis in systemic sclerosis patients.
    Sebastiani M; Giuggioli D; Vesprini E; Caruso A; Ferri C
    Rheumatology (Oxford); 2006 Sep; 45(9):1175-6. PubMed ID: 16820378
    [No Abstract]   [Full Text] [Related]  

  • 3. Abatacept induces clinical improvement in patients with severe systemic sclerosis.
    de Paoli FV; Nielsen BD; Rasmussen F; Deleuran B; Søndergaard K
    Scand J Rheumatol; 2014; 43(4):342-5. PubMed ID: 25088011
    [No Abstract]   [Full Text] [Related]  

  • 4. Discordant response to rituximab in a systemic sclerosis patient with associated myositis.
    Fabri M; Hunzelmann N; Krieg T; Rubbert A
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S127-8. PubMed ID: 18489049
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Ann Rheum Dis; 2003 Oct; 62(10):1019-20. PubMed ID: 12972489
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide therapy for scleroderma.
    Akesson A
    Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.
    Liozon E; Ouattara B; Loustaud-Ratti V; Vidal E
    Scand J Rheumatol; 2007; 36(6):484-6. PubMed ID: 18092275
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine in the treatment of an unusual case of juvenile systemic sclerosis.
    al-Mayouf SM; Silverman ED; Feldman BM; Thorner P; Laxer RM
    J Rheumatol; 1998 Apr; 25(4):791-3. PubMed ID: 9558187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma.
    Ozgen M; Koca SS; Isik A; Ozercan IH
    J Rheumatol; 2010 Mar; 37(3):678-9. PubMed ID: 20197571
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancytopenia in a patient with scleroderma treated with infliximab.
    Menon Y; Cucurull E; Espinoza LR
    Rheumatology (Oxford); 2003 Oct; 42(10):1273-4; author reply 1274. PubMed ID: 14508054
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rheumatology--a glimpse of a rapidly developing discipline].
    Baslund B; Madsen OR; Søndergaard K; Juul L
    Ugeskr Laeger; 2012 Mar; 174(12):804. PubMed ID: 22433561
    [No Abstract]   [Full Text] [Related]  

  • 12. [Two cases of successfully treated multifocal fibrosis].
    Guseva NG; Nevskaia TA; Starovoĭtova MN
    Ter Arkh; 2002; 74(5):77-9. PubMed ID: 12087915
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-TNF-alpha-treatment of arthritis--4-year follow-up].
    Petri A; Dreyer L; Danneskiold-Samsøe B; Terslev L; Bliddal H
    Ugeskr Laeger; 2003 Nov; 165(48):4649-52. PubMed ID: 14677465
    [No Abstract]   [Full Text] [Related]  

  • 14. New treatments in scleroderma: the rheumatologic perspective.
    Righi A; Cerinic MM
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):431-2. PubMed ID: 12428830
    [No Abstract]   [Full Text] [Related]  

  • 15. Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosis.
    Holmberg LA; Furst DE; McSweeney PA; Nash RA
    J Rheumatol; 2009 Aug; 36(8):1839. PubMed ID: 19671826
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.
    McGonagle D; Tan AL; Madden J; Rawstron AC; Rehman A; Emery P; Thomas S
    Rheumatology (Oxford); 2008 Apr; 47(4):552-3. PubMed ID: 18281368
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1.
    Sprott H; Glatzel M; Michel BA
    Rheumatology (Oxford); 2004 Apr; 43(4):524-6. PubMed ID: 15024139
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate for the treatment of early diffuse scleroderma: comment on the article by Pope et al.
    Lehman TJ
    Arthritis Rheum; 2002 Mar; 46(3):845. PubMed ID: 11920427
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
    Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
    Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of scleroderma.
    Gelber AC; Wigley FM
    Curr Opin Rheumatol; 1995 Nov; 7(6):551-9. PubMed ID: 8579978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.